Small Molecule Prodrugs
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
69
NCT04309526
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 18, 2020
Completion: Oct 13, 2020
NCT04629976
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
Start: Jan 12, 2021
Completion: Dec 28, 2022